Area of research
Applied Microbiology and Biotechnology · Infectious Diseases
Research interest
Research interests include Antibiotic Use and Resistance, Vaccine Coverage and Hesitancy, Nosocomial Infections in ICU, and SARS-CoV-2 and COVID-19 Research.
Urine culture and urinalysis utilization practices in United States acute care hospitals between 2017 and 2020.
Trends in Incidence and Epidemiology of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia, Six Emerging Infections Program Surveillance Sites, 2005–2022
Changes in Carbapenemase-Producing Carbapenem-Resistant Enterobacterales, 2019 to 2023.
Trends in Incidence and Epidemiology of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia, Six Emerging Infections Program Surveillance Sites, 2005-2022.
Comparison of Medicare claims-based <i>Clostridioides difficile</i> infection epidemiologic case classification algorithms to medical record review by the Emerging Infections Program using a linked cohort, 2016-2021.
Effectiveness of COVID-19 bivalent vaccination against SARS-CoV-2 infection among residents of US nursing homes, November 2022 – March 2023
Length of antibiotic therapy among adults hospitalized with uncomplicated community-acquired pneumonia, 2013-2020.
Measuring the Direct Medical Costs of Hospital-Onset Infections Using an Analogy Costing Framework.
Changes in the Incidence of Invasive Bacterial Disease During the COVID-19 Pandemic in the United States, 2014–2020
Post-authorization safety surveillance of Ad.26.COV2.S vaccine: Reports to the Vaccine Adverse Event Reporting System and v-safe, February 2021-February 2022.
Trends in facility-level rates of <i>Clostridioides difficile</i> infections in US hospitals, 2019-2020.
Trimethoprim-sulfamethoxazole resistance patterns among <i>Staphylococcus aureus</i> in the United States, 2012-2018.
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) outbreaks in nursing homes involving residents who had completed a primary coronavirus disease 2019 (COVID-19) vaccine series-13 US jurisdictions, July-November 2021.
Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017
National Estimates of Healthcare Costs Associated With Multidrug-Resistant Bacterial Infections Among Hospitalized Patients in the United States
Surgical site infection risk following cesarean deliveries covered by Medicaid or private insurance.
Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015
Vital signs: improving antibiotic use among hospitalized patients.
PubMed 2014cited by 376position: middle
Intussusception After Rotavirus Vaccines Reported to US VAERS, 2006–2012